Biotechnology News

April 26, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, has been named one of the “Best Places to Work in New...

April 26, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced that it will webcast today’s corporate presentation at 9:15 a.m. PDT, after the formal portion of...

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Senomyx, Inc. (NASDAQ:SNMX), will release its financial results for the first quarter ended March 31, 2012 on Thursday, May 3, 2012 before the opening of the U.S. financial markets. The Company will also host a...

April 26, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company, announced that the company will host a conference call and webcast on May 7, 2012 at 4:30 p.m. Eastern time to discuss its first...

April 26, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients...

April 26, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the first quarter of 2012 on Thursday, May 3, 2012 at 7:00 a.m. eastern time. The Company will hold a conference call at 9:...

April 26, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today it has exercised its option and completed the purchase of SIGMA International General Medical Apparatus, LLC., a privately held company based in Medina, New...

April 26, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced its support of the North Atlantic Treaty Organization (NATO) Emerging Security Challenges Division (ESCD) in hosting a biopreparedness workshop entitled “A Bio...

April 26, 2012

SEATTLE--(BUSINESS WIRE)--Cadence Biomedical, a provider of medical devices that help people with severe disabilities walk, announced the closing of an oversubscribed $1.1 million Series A2 financing led by HealthTech Capital. Other investors...

April 26, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2012 financial results after the close of the market on Thursday, May 3, 2012. The company plans to hold a...

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem to present at Deutsche Bank 37th Annual Health Care Conference on May 9, 2012.

April 26, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced interim data from a prospective, open label survey study evaluating spasticity in patients with relapsing-remitting multiple sclerosis (RRMS) who...

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced Dallas-based AHI Facility Services, Inc. as a regional strategic customer in the contract...

April 26, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported record fiscal 2012 second quarter and six months net sales of $47.4 million and $...

April 26, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Based on the success of the collaboration up, Novartis has exercised its second option to extend its oncology discovery research collaboration with Zalicus for an additional contract year

April 26, 2012

CAMBRIDGE, Mass. & SUMMIT, N.J.--(BUSINESS WIRE)--Epizyme and Celgene announced a partnership to discover, develop and commercialize personalized therapeutics for patients with genetically-defined cancers. Epizyme will receive $90 million up...

April 26, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is reporting record revenue and profits for first quarter of 2012.

April 26, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported Non-GAAP net product sales of $1,245 million for the first quarter of 2012, a 17 percent increase from the same period in 2011. Non-GAAP net income for the first quarter...

April 26, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three months ended March 31, 2012. For the first quarter ended March 31, 2012, the Company reported revenue of $59.5 million,...

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended March 31, 2012.

April 26, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today reported first-quarter 2012 financial results, including revenue from its first commercial product, JakafiTM (ruxolitinib), which was approved by the US Food & Drug...

April 26, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Confirms Takeda’s Receipt of Complete Response Letter from the FDA for Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that financial results for the company's first quarter ended March 31, 2012 will be released before the market opens on Thursday, May 3, 2012. The AVEO...

April 26, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Steady growth and expansion at our partner companies, despite the fragile state of the macro-economy, continues to validate Safeguard’s strategic focus.

April 26, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: FIRST QUARTER 2012 · NET SALES amounted to MSEK 30.6 (23.9). · OPERATING PROFIT totalled MSEK 8.5 (6.8). · PROFIT AFTER TAX amounted to MSEK 6.4 (5.1). · PROFIT AFTER TAX PER SHARE was 0.71 SEK (0....

April 26, 2012

MONTPELLIER, France--(BUSINESS WIRE)--Online news publication in-PharmaTechnologist.com today launched a refocused website to deliver more targeted news in key biopharma manufacturing niches.

April 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced that it will release first quarter 2012 financial results after market close on Tuesday, May 8, 2012. Santarus management will host an investment-community conference call...

April 26, 2012

TOKYO & NEW YORK--(BUSINESS WIRE)--Asahi Kasei Corporation (TSE1: 3407, hereinafter: Asahi Kasei), Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction...

April 26, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Fingerprint Cards AB (publ)(STO:FINGB), Corp. Reg. No. 556154-2381, (FPC) First quarter, 2012: · Sales totaled SEK 5.2 M (12.8). · According to the new calculation method, a gross loss of SEK 0.3 M (...

April 26, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc, today reported its first quarter 2012 financial results. “Our first quarter financial performance was solid and represents a good start to the year across all aspects of our business,” said Mr....

April 25, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its second quarter 2012 conference call...

April 25, 2012

WASHINGTON--(BUSINESS WIRE)--Five groups today wrote leaders of the Senate Appropriations Committee asking them to authorize the DOE to transfer funds to an interagency project to ramp up production of military aviation biofuels

April 25, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Deutsche Bank 37th Annual Healthcare...

April 25, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Fortinet (NASDAQ: FTNT), a leader in high-performance network security, and Gilead Sciences, Inc. (NASDAQ: GILD), a leading biopharmaceutical company, received 2012 GROW! Awards from ACG Silicon Valley at a...

April 25, 2012

WILMINGTON, Del. & PARSIPPANY, N.J.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) and The Medicines Company (NASDAQ: MDCO) announced today a global collaboration for acute ischemic heart disease compounds. The first part of this collaboration is...

April 25, 2012

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular Announces Lipoparticle Distribution in Japan by Funakoshi

April 25, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The merger and acquisition market for the health care industry posted strong gains in the first quarter of 2012 over previous periods.

April 25, 2012

ZURICH & GRENOBLE, France--(BUSINESS WIRE)--Cutting-edge medtech business leaders and senior executives set to attend EuroMedtech 2012

April 25, 2012

WAUWATOSA, Wis.--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced the FDA clearance and availability of the latest version of its Vivid E9™ cardiovascular ultrasound system. The Vivid E9 Breakthrough...

April 25, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced a reduction in force as part of a strategic plan to focus the company’s resources...

April 25, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced a reduction in force as part of a strategic plan to focus the company’s resources...

April 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Drug & device companies are still waiting for the U.S. Centers for Medicare and Medicaid Services (CMS) to issue its final ruling on how it will implement the Physician Payments Sunshine Act

April 25, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE AMEX: NAVB) Announces Participation in Alzheimer’s Disease Scientific Meetings.

April 25, 2012

WOODRIDGE, Ill.--(BUSINESS WIRE)--Online Business Applications has launched a lighter, Web-based version of its IRMS software, IRMS-CE.

April 25, 2012

ANDOVER, Mass.--(BUSINESS WIRE)--Capsule's video series educates healthcare organizations on the key role that medical device integration (MDI) plays in improving healthcare IT. The second video discusses hardware & implementation.

April 25, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--A new public cord blood collection program at Packard Children's is now enabling new parents to donate their baby's cord blood to an international stem cell transplant registry.

April 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix has been awarded two new patents from the U.S. Patent and Trademark Office (PTO) related to the novel and efficient production of biobased polymers and industrial chemicals.